1. Home
  2. AROW vs ATXS Comparison

AROW vs ATXS Comparison

Compare AROW & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AROW
  • ATXS
  • Stock Information
  • Founded
  • AROW 1851
  • ATXS 2008
  • Country
  • AROW United States
  • ATXS United States
  • Employees
  • AROW N/A
  • ATXS N/A
  • Industry
  • AROW Major Banks
  • ATXS Biotechnology: Pharmaceutical Preparations
  • Sector
  • AROW Finance
  • ATXS Health Care
  • Exchange
  • AROW Nasdaq
  • ATXS Nasdaq
  • Market Cap
  • AROW 418.8M
  • ATXS 401.2M
  • IPO Year
  • AROW N/A
  • ATXS 2015
  • Fundamental
  • Price
  • AROW $25.06
  • ATXS $5.28
  • Analyst Decision
  • AROW Hold
  • ATXS Strong Buy
  • Analyst Count
  • AROW 1
  • ATXS 7
  • Target Price
  • AROW $28.00
  • ATXS $32.43
  • AVG Volume (30 Days)
  • AROW 42.3K
  • ATXS 618.7K
  • Earning Date
  • AROW 07-24-2025
  • ATXS 05-13-2025
  • Dividend Yield
  • AROW 4.44%
  • ATXS N/A
  • EPS Growth
  • AROW N/A
  • ATXS N/A
  • EPS
  • AROW 1.70
  • ATXS N/A
  • Revenue
  • AROW $135,107,000.00
  • ATXS N/A
  • Revenue This Year
  • AROW $23.54
  • ATXS N/A
  • Revenue Next Year
  • AROW $7.07
  • ATXS N/A
  • P/E Ratio
  • AROW $15.02
  • ATXS N/A
  • Revenue Growth
  • AROW 3.10
  • ATXS N/A
  • 52 Week Low
  • AROW $22.72
  • ATXS $3.56
  • 52 Week High
  • AROW $34.63
  • ATXS $12.92
  • Technical
  • Relative Strength Index (RSI)
  • AROW 42.15
  • ATXS 62.65
  • Support Level
  • AROW $25.44
  • ATXS $3.83
  • Resistance Level
  • AROW $26.54
  • ATXS $4.98
  • Average True Range (ATR)
  • AROW 0.50
  • ATXS 0.39
  • MACD
  • AROW -0.15
  • ATXS 0.15
  • Stochastic Oscillator
  • AROW 0.00
  • ATXS 91.17

About AROW Arrow Financial Corporation

Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of company's revenue is interest income, fees, commission earned through its subsidiaries.

About ATXS Astria Therapeutics Inc.

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.

Share on Social Networks: